Genovis acquires all shares in QED Bioscience Inc., San Diego, CA, USA
Today Genovis acquired all shares in the privately held company QED Bioscience Inc. (QED), based in San Diego, California, USA. Genovis is paying about SEK 20 million in cash for the acquisition, including transaction costs. With a broadened product selection and a larger market, the company believes that after the acquisition it will be well-positioned to capture a larger share of the market for antibody labeling and associated contract research.As a result of the acquisition, Genovis will gain a well-established supplier of high-quality antibodies and a dedicated team with extensive